Immunopathogenesis of vaccine-enhanced RSV disease

This publication has 32 references indexed in Scilit:

• Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.
  The Journal of Experimental Medicine, 1995
• Treatment and prevention of severe respiratory syncytial virus infection in young children
  Current Opinion in Infectious Diseases, 1995
• Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSV
  Vaccine, 1992
• Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
  Vaccine, 1990
• Development of cell‐mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection
  Journal of Medical Virology, 1989
• Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level
  The Journal of Pediatrics, 1981
• Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity
  The Journal of Pediatrics, 1980
• Cell-mediated immune response to respiratory syncytial virus infection: Relationship to the development of reactive airway disease
  The Journal of Pediatrics, 1979
• Development of in Vitro Correlates of Cell-Mediated Immunity to Respiratory Syncytial Virus Infection in Humans
  The Journal of Infectious Diseases, 1978
• Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines
  JAMA, 1967